Axsome Therapeutics Inc (AXSM)

82.57 -1.21 (-1.44%) USD  |  NASDAQ  |  Jan 08, 16:00
82.65 +0.08 (+0.10%) After-Hours: 20:00
More

Axsome Therapeutics Research and Development Expense (Annual): 97.94M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Repligen Corp 42.72M
Pfizer Inc 10.68B
Marinus Pharmaceuticals Inc 99.39M
NovaBay Pharmaceuticals Inc 0.068M
Palatin Technologies Inc 22.40M